I agree that this site is using cookies. You can find further informations here.
X
Drilon, A.
479  results:
Search for persons X
?
1

43P Updated efficacy and circulating tumour (ct)DNA analysi..:

Drilon, A. ; Lin, J.J. ; Tan, D.S.W....
ESMO Open.  9 (2024)  - p. 102622 , 2024
Link: https://doi.org/10.1016/..
 
?
2

147P Population-adjusted indirect comparisons of repotrecti..:

Wolf, J. ; Goring, S. ; Lee, A....
ESMO Open.  9 (2024)  - p. 102734 , 2024
Link: https://doi.org/10.1016/..
 
?
3

35P Final data from phase I/II LIBRETTO-001 trial of selper..:

Gautschi, O. ; Drilon, A. ; Solomon, B....
ESMO Open.  9 (2024)  - p. 102614 , 2024
Link: https://doi.org/10.1016/..
 
?
4

PCR181 Health-Related Quality-of-Life of Patients Treated w..:

Sherif, B. ; Besse, B. ; Solomon, B....
Value in Health.  26 (2023)  12 - p. S484 , 2023
Link: https://doi.org/10.1016/..
 
?
5

74P Tumor agnostic comparison of immunohistochemistry and n..:

Chen, M.F. ; Yang, S.R. ; Chang, J...
ESMO Open.  8 (2023)  1 - p. 100932 , 2023
Link: https://doi.org/10.1016/..
 
?
6

MA06.08 Real-World Landscape Analysis of Activating ERBB2/E..:

Liu, D. ; Jee, J. ; Keller, R.B....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S120-S121 , 2023
Link: https://doi.org/10.1016/..
 
?
7

15MO Efficacy and ctDNA analysis in an updated cohort of pa..:

Hoejgaard, M. ; Drilon, A. ; Lin, J.J....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S48-S49 , 2023
Link: https://doi.org/10.1016/..
 
?
8

88P Evaluation of trending drug targets and technologies in..:

Repetto, M. ; Crimini, E. ; Belli, C....
ESMO Open.  8 (2023)  1 - p. 100946 , 2023
Link: https://doi.org/10.1016/..
 
?
9

OA19.05 Activating MET Tyrosine Kinase Domain Mutations as ..:

Nakazawa, S. ; Pecci, F. ; Ricciuti, B....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S88-S89 , 2023
Link: https://doi.org/10.1016/..
 
?
10

81TiP NVL-655, a selective anaplastic lymphoma kinase (ALK)..:

Johnson, M.L. ; Ou, S-H.I. ; Felip, E....
Journal of Thoracic Oncology.  18 (2023)  4 - p. S86-S87 , 2023
Link: https://doi.org/10.1016/..
 
?
11

EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET An..:

Drilon, A. ; Awad, M.M. ; Camidge, D.R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S602-S603 , 2023
Link: https://doi.org/10.1016/..
 
?
12

P1.21-12 Microsatellite Instability Defines a Subset of Lun..:

Yang, S.-R. ; Gedvilaite, E. ; Ptashkin, R....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S239 , 2023
Link: https://doi.org/10.1016/..
 
?
13

OA03.06 Repotrectinib in Patients with ROS1 Fusion-positive..:

Cho, B.C. ; Camidge, D.R. ; Lin, J.J....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S50-S51 , 2023
Link: https://doi.org/10.1016/..
 
?
14

EP08.02-041 NVL-520, a Highly Selective ROS1 Inhibitor, in ..:

Drilon, A. ; Ou, S.-H.I. ; Gadgeel, S....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S416 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Pivotal topline data from the phase 1/2 TRIDENT-1 trial of ..:

Cho, B.C. ; Lin, J. ; Camidge, D.R....
European Journal of Cancer.  174 (2022)  - p. S1-S2 , 2022
Link: https://doi.org/10.1016/..
 
1-15